Lack of Standardized Vitamin D Data Hampers Efforts to Determine Its Role in Parkinson’s, Review Study Says
Low vitamin D serum levels have been associated with Parkinson’s disease, but the lack of standardized data makes it…
Articles by Catarina Silva, MSc
Real-World Data Links High-Blood Pressure Therapy With Parkinsonism, Researchers Report
Propranolol, a beta-blocker therapy for high-blood pressure, may be associated with an increased risk of developing parkinsonism —…
Bacteria in Gut Can Promote Parkinson’s by Altering Brain’s Immune Reactions, Study Says
Bacterial infections in the intestines may trigger Parkinson’s progression by altering the immune system and damaging dopaminergic neurons, according…
Oxidative Stress Seen Promote Spread of Toxic Alpha-Synuclein Across Cells, Possibly Trigger Disease
Oxidative stress may be a trigger for Parkinson’s and can promote its progression by facilitating the spread of toxic alpha-synuclein protein…
High Levels of Zinc Found in Hair of Parkinson’s Patients with Depression, Psychiatric Symptoms, Study Says
Parkinson’s disease patients with either depression or psychiatric symptoms such as hallucinations, confusion, or illusion may have higher levels…
Poor Sleep Most Common in Patients with Central Parkinsonian Pain, Study Finds
People with generalized pain related to their Parkinson’s are prone to disturbed nighttime sleep, a reason these two disease symptoms…
Brain Changes Might Predict Parkinson’s Mild Cognitive Impairment
Early atrophy of a speech-related brain area called temporal lobe and progressive degeneration of a cognitive one (frontal lobe) might…
Protein-linked Sugars Regulate the Spread of Alpha-synuclein, Study Suggests
A protein that has sugar molecules attached to it, called neurexin 1-beta, helps alpha-synuclein enter and accumulate within neurons contributing…
Specific Form of Alpha-Synuclein Linked to More Severe Parkinson’s Symptoms in Early Study
Small amounts of a particular form of alpha-synuclein, known as beta-sheet, may cause a significant loss of dopamine-releasing neurons by…
Cannabinoid-based Possible Treatment for Parkinson’s, EHP-102, Seen as Superior to New Molecules in Early Test
Emerald Health Pharmaceuticals announced that two of its cannabinoid-derived candidates — CBGA-Q and CBGA-Q-Na Salt — showed anti-inflammatory and…